Adaptimmune Therapeutics plc American Depositary Shares (ADAP) Operating Margin (2015 - 2025)
Adaptimmune Therapeutics plc American Depositary Shares (ADAP) operating margin from Jun 30, 2015 to Jun 30, 2025. The current Adaptimmune Therapeutics plc American Depositary Shares (ADAP) operating margin is -221.42%. You can export chart.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Adaptimmune Therapeutics plc American Depositary Shares (ADAP)
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -38.62% | -83.34% |
| 2023 | -231.82% | -61.61% |
| 2022 | -603.90% | -72.87% |
| 2021 | -2225.83% | +6.46% |
| 2020 | -2090.75% | -40.63% |
| 2019 | -3521.85% | +2661.41% |
| 2018 | -127.54% | -40.18% |
| 2017 | -213.22% | -58.41% |
| 2016 | -512.68% | N/A |
Comparison Adaptimmune Therapeutics plc American Depositary Shares (ADAP) operating margin with competitors
Adaptimmune Therapeutics plc American Depositary Shares (ADAP) operating margin is -221.42%.